Asthma is common and severe types are often uncontrolled

Asthma is one of the top five chronic diseases globally, along with heart disease, stroke, cancer and diabetes.1

Asthma affects an estimated 300 million people worldwide and 30 million people in Europe.2

There has been a sharp increase in the global prevalence, morbidity, mortality, and economic burden associated with asthma since the 1960s, particularly in children, and the global prevalence is expected to grow to as many as 400-500 million people by 2025.2,3

Approximately 18% of Europeans with asthma have the severe form of the disease (symptoms that occur throughout the day on most days and during the night), and 20% of these patients are uncontrolled.2,4,5

Asthma greatly impacts quality of life
Asthma is under-diagnosed and under-treated, creating a substantial burden to individuals and their families, which they will potentially have to deal with for the rest of their lives.1 Unlike many chronic diseases, asthma occurs in all countries regardless of level of development.1

Inadequately managed severe asthma causes a large burden in terms of morbidity and mortality.6 Patients with severe asthma often have significantly impaired quality of life, are frequently absent from school or work, have decreased productivity, and are at an increased risk of hospital admission and death.6